Sangamo Biosciences Short Ratio

The Macroaxis Equity Filters allow users to customize the simple screener criteria below or select from a set of available quick indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Short Ratio Analysis

Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Sangamo Biosciences 
Short Ratio 
 = 
Short Interest 
Average Trading Volume 
 = 
9.55 times

Distress Driver Correlations

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare to competition
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 9.55 times. This is much higher than that of the sector, and significantly higher than that of Pharmaceutical Products industry, The Short Ratio for all stocks is over 1000% lower than the firm.
Peer Comparison
Sangamo Biosciences Short Ratio Comparison
  Short Ratio 
Benchmark  Embed    Sangamo Biosciences Comparables 
Sangamo Biosciences is currently under evaluation in short ratio category among related companies.
Did you try this?
Run Equity Valuation Now
   

Equity Valuation

Check real value of public entities based on technical and fundamental data
Hide  View All  Next  Launch Equity Valuation
Return On Equity(20.40) %
Return On Asset(17.68) %
Profit Margin(0.0003) %
Operating Margin(368.76) %
Current Valuation605.24 M
Shares Outstanding69.76 M
Shares Owned by Insiders4.18 %
Shares Owned by Institutions71.00 %
Number of Shares Shorted8.63 M
Price to Earning(15.74) times
Price to Book1.42 times
Price to Sales10.46 times
Revenue39.54 M
Gross Profit39.54 M
EBITDA(65.46 M)
Net Income(40.7 M)
Cash and Equivalents69.48 M
Cash per Share2.06 times
Total Debt285 K
Debt to Equity0.13 times
Current Ratio10.73 times
Book Value Per Share2.74 times
Cash Flow from Operations(33.72 M)
Short Ratio9.55 times
Earnings Per Share(1.08) times
Number of Employees119
Beta2.94
Market Capitalization639.53 M
Total Asset217.24 M
Retained Earnings(369.25 M)
Working Capital192.49 M
Current Asset212.58 M
Current Liabilities20.1 M
Z Score1344.4